These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 36120106)

  • 21. Cocaine-like discriminative stimulus effects of heroin in squirrel monkeys: role of active metabolites and opioid receptor mechanisms.
    Rowlett JK; Spealman RD; Platt DM
    Psychopharmacology (Berl); 2000 Jun; 150(2):191-9. PubMed ID: 10907672
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Safety and feasibility of intranasal heroin-assisted treatment: 4-week preliminary findings from a Swiss multicentre observational study.
    Vogel M; Meyer M; Westenberg JN; Kormann A; Simon O; Salim Hassan Fadlelseed R; Kurmann M; Bröer R; Devaud N; Sanwald U; Baumgartner S; Binder H; Strasser J; Krausz RM; Beck T; Dürsteler KM; Falcato L
    Harm Reduct J; 2023 Jan; 20(1):2. PubMed ID: 36611162
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Laser meridian massage decreased craving in men with opioid use disorder on methadone maintenance treatment.
    Hu WL; Tsai MC; Kuo CE; Liu CT; Wu SY; Wu TC; Hung YC
    Biomed J; 2022 Apr; 45(2):414-423. PubMed ID: 35595647
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Exposure to fentanyl-contaminated heroin and overdose risk among illicit opioid users in Rhode Island: A mixed methods study.
    Carroll JJ; Marshall BDL; Rich JD; Green TC
    Int J Drug Policy; 2017 Aug; 46():136-145. PubMed ID: 28578864
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Opioid reinforcement in heroin-dependent volunteers during outpatient buprenorphine maintenance.
    Greenwald MK; Johanson CE; Schuster CR
    Drug Alcohol Depend; 1999 Oct; 56(3):191-203. PubMed ID: 10529021
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of the reinforcing and subjective effects of heroin in combination with dextromethorphan and quinidine.
    Vosburg SK; Sullivan MA; Comer SD
    J Opioid Manag; 2011; 7(6):451-61. PubMed ID: 22320027
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Variability in prescription opioid intake and reinforcement amongst 129 substrains.
    Jimenez SM; Healy AF; Coelho MA; Brown CN; Kippin TE; Szumlinski KK
    Genes Brain Behav; 2017 Sep; 16(7):709-724. PubMed ID: 28523735
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Attenuation of cocaine and heroin seeking by μ-opioid receptor antagonism.
    Giuliano C; Robbins TW; Wille DR; Bullmore ET; Everitt BJ
    Psychopharmacology (Berl); 2013 May; 227(1):137-47. PubMed ID: 23299095
    [TBL] [Abstract][Full Text] [Related]  

  • 29. «One prick and then it´s done»: a mixed-methods exploratory study on intramuscular injection in heroin-assisted treatment.
    Meyer M; Eichenberger R; Strasser J; Dürsteler KM; Vogel M
    Harm Reduct J; 2021 Dec; 18(1):134. PubMed ID: 34922561
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intervention in an opioid overdose event increases interest in treatment among individuals with opioid use disorder.
    Jones JD; Campbell AN; Brandt L; Castillo F; Abbott R; Comer SD
    Subst Abus; 2021; 42(4):407-411. PubMed ID: 32814002
    [No Abstract]   [Full Text] [Related]  

  • 31. Effectiveness of adjunctive, personalised psychosocial intervention for non-response to opioid agonist treatment: Study protocol for a pragmatic randomised controlled trial.
    Marsden J; Stillwell G; Hellier J; Brown AM; Byford S; Kelleher M; Kelly J; Murphy C; Shearer J; Mitcheson L
    Contemp Clin Trials; 2017 Feb; 53():36-43. PubMed ID: 27940188
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modeling Mitigation Strategies to Reduce Opioid-Related Morbidity and Mortality in the US.
    Ballreich J; Mansour O; Hu E; Chingcuanco F; Pollack HA; Dowdy DW; Alexander GC
    JAMA Netw Open; 2020 Nov; 3(11):e2023677. PubMed ID: 33146732
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An examination of motives for tramadol and heroin use in an Egyptian sample.
    AbdelWahab MA; Abou El Magd SF; Grella CE; Enaba DA; Abdel Maqsoud R
    J Addict Dis; 2018; 37(3-4):123-134. PubMed ID: 31264937
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acute treatment with the glucagon-like peptide-1 receptor agonist, liraglutide, reduces cue- and drug-induced fentanyl seeking in rats.
    Urbanik LA; Acharya NK; Grigson PS
    Brain Res Bull; 2022 Oct; 189():155-162. PubMed ID: 36031011
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterizing the subjective, observer-rated, and physiological effects of hydromorphone relative to heroin in a human laboratory study.
    Dunn KE; Brands B; Marsh DC; Bigelow GE
    Psychopharmacology (Berl); 2018 Apr; 235(4):971-981. PubMed ID: 29270641
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic deletion of the dopamine D3 receptor increases vulnerability to heroin in mice.
    Zhan J; Jordan CJ; Bi GH; He XH; Gardner EL; Wang YL; Xi ZX
    Neuropharmacology; 2018 Oct; 141():11-20. PubMed ID: 30138692
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Trends in Urine Drug Monitoring Among Persons Receiving Long-Term Opioids and Persons with Opioid Use Disorder in the United States.
    Sohn M; Talbert JC; Huang Z; Oser C; Freeman PR
    Pain Physician; 2021 Mar; 24(2):E249-E256. PubMed ID: 33740362
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Add-on repetitive transcranial magnetic stimulation in patients with opioid use disorder undergoing methadone maintenance therapy.
    Tsai TY; Wang TY; Liu YC; Lee PW; Chang WH; Lu TH; Tseng HH; Lee SY; Chang YH; Yang Y; Chen PS; Chen KC; Yang YK; Lu RB
    Am J Drug Alcohol Abuse; 2021 May; 47(3):330-343. PubMed ID: 33426970
    [No Abstract]   [Full Text] [Related]  

  • 39. "I'm a Survivor": Perceptions of Chronic Disease and Survivorship Among Individuals in Long-Term Remission from Opioid Use Disorder.
    Pytell JD; Sklar MD; Carrese J; Rastegar DA; Gunn C; Chander G
    J Gen Intern Med; 2022 Feb; 37(3):593-600. PubMed ID: 34027611
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment utilization among persons with opioid use disorder in the United States.
    Wu LT; Zhu H; Swartz MS
    Drug Alcohol Depend; 2016 Dec; 169():117-127. PubMed ID: 27810654
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.